Molecular bases of comorbidities: present and future perspectives

Trends Genet. 2023 Jul 21:S0168-9525(23)00134-8. doi: 10.1016/j.tig.2023.06.003. Online ahead of print.ABSTRACTCo-occurrence of diseases decreases patient quality of life, complicates treatment choices, and increases mortality. Analyses of electronic health records present a complex scenario of comorbidity relationships that vary by age, sex, and cohort under study. The study of similarities between diseases using 'omics data, such as genes altered in diseases, gene expression, proteome, and microbiome, are fundamental to uncovering the origin of, and potential treatment for, comorbidities. Recent studies have produced a first generation of genetic interpretations for as much as 46% of the comorbidities described in large cohorts. Integrating different sources of molecular information and using artificial intelligence (AI) methods are promising approaches for the study of comorbidities. They may help to improve the treatment of comorbidities, including the potential repositioning of drugs.PMID:37482451 | DOI:10.1016/j.tig.2023.06.003
Source: Trends in Genetics : TIG - Category: Genetics & Stem Cells Authors: Source Type: research